According to Dan Rizzo, vice president of global business consulting at Veeva Systems, no one knows how quickly field teams will gain physical access to the HCPs, but the truth is, 50% of HCPs didn’t allow physical access to sales reps prior to COVID. Where the industry is now, in response to stranded field teams, is the need to optimize any digital engagement they did have. To that end, Veeva announced Accenture, Deloitte, and other partners will support the execution of Veeva’s Digital Field Engagement offering, which provides more direction or “roadmap” for customers to connect with HCPs digitally.
Building upon the company’s offering of Veeva CRM Engage Meeting for free to existing CRM customers since earlier last month, the Digital Field Engagement solution offers a four-week engagement outline that defines roles, responsibilities, tools, data and training for companies using other Veeva digital tools.
“Essentially, how do you crawl, walk and then run with the best use of technology that you already have? What expectations do you set for your sales representatives on facilitating conversations, making sure that you're leading with empathy at this time?” Rizzo elaborated. “What type of measurement do you need to get the right type of coaching and of where field reps are struggling with using this new technology versus we're doing okay?”
For more information, click here.
Reshema Kemps-Polanco: Taking Risks for Greater Reward
May 14th 2025Reshema Kemps-Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of the Year, uses the lessons she learned from her family to bring out the best in her teams.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Novo Nordisk’s Sogroya Demonstrates Efficacy in Children with Growth Disorders
May 14th 2025Results from the Phase III REAL8 basket study found that once-weekly Sogroya was effective in children with growth disorders, including those born small for gestational age, with Noonan syndrome, or idiopathic short stature.